What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
David B. Badesch spends much of his time researching Pulmonary hypertension, Internal medicine, Cardiology, Surgery and Randomized controlled trial.
His Pulmonary hypertension study combines topics from a wide range of disciplines, such as Hemodynamics, Anesthesia and Respiratory disease.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Endocrinology.
The various areas that David B. Badesch examines in his Cardiology study include Expert consensus and Blood pressure.
David B. Badesch has included themes like Vascular resistance and Associated Pulmonary Arterial Hypertension in his Surgery study.
The concepts of his Randomized controlled trial study are interwoven with issues in Treprostinil and Clinical trial.
His most cited work include:
- Bosentan therapy for pulmonary arterial hypertension. (2301 citations)
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension (2191 citations)
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association (1995 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Pulmonary hypertension, Cardiology, Surgery and Hemodynamics.
The Internal medicine study which covers Gastroenterology that intersects with Clinical endpoint.
The Pulmonary hypertension study combines topics in areas such as Anesthesia, Respiratory disease, Prostacyclin and Intensive care medicine.
His Cardiology study frequently involves adjacent topics like Disease.
His study connects Associated Pulmonary Arterial Hypertension and Surgery.
While the research belongs to areas of Randomized controlled trial, he spends his time largely on the problem of Clinical trial, intersecting his research to questions surrounding Treprostinil.
He most often published in these fields:
- Internal medicine (63.88%)
- Pulmonary hypertension (56.83%)
- Cardiology (36.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (63.88%)
- Pulmonary hypertension (56.83%)
- Cardiology (36.56%)
In recent papers he was focusing on the following fields of study:
David B. Badesch mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Emergency medicine and Idiopathic Pulmonary Arterial Hypertension.
His Internal medicine study incorporates themes from Gastroenterology and Oncology.
In his works, David B. Badesch undertakes multidisciplinary study on Pulmonary hypertension and Association.
His Cardiology research focuses on Lung and how it relates to Observational study, Hypoxemia and Supportive psychotherapy.
His Emergency medicine research focuses on subjects like Symptom reporting, which are linked to Clinical trial.
David B. Badesch interconnects Health equity and Portopulmonary hypertension in the investigation of issues within Idiopathic Pulmonary Arterial Hypertension.
Between 2017 and 2021, his most popular works were:
- Diagnosis of pulmonary hypertension (112 citations)
- Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report. (86 citations)
- Exercise-Induced Pulmonary Hypertension: Translating Pathophysiological Concepts Into Clinical Practice (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Intensive care medicine, Cardiology and Clinical trial.
In general Internal medicine, his work in Associated Pulmonary Arterial Hypertension, Randomized controlled trial and Vascular resistance is often linked to In patient and Genetic association linking many areas of study.
His Pulmonary hypertension study combines topics in areas such as Health related quality of life, Quality of life, Emergency medicine, Risk stratification and Survival data.
David B. Badesch focuses mostly in the field of Intensive care medicine, narrowing it down to topics relating to Disease and, in certain cases, Right heart failure, Registry data, Increased pulmonary vascular resistance and Health economics.
His research in Cardiology intersects with topics in Lung, Overall survival and Receiver operating characteristic.
His studies deal with areas such as Treprostinil, Combination therapy, Exercise capacity, Clinical study and Double blind as well as Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
